Related Experiment Videos
Watch-and-wait strategy in rectal cancer - Authors' reply
Sami A Chadi1, Geerard L Beets2, Rodrigo O Perez3
1Division of Surgical Oncology and General Surgery, Princess Margaret Hospital and University Health Network, University of Toronto, Toronto, ON, Canada.
The Lancet. Gastroenterology & Hepatology
|January 17, 2019
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cancer early detection research priorities in some underrepresented communities: a commentary of the learnings from a community priority setting project.
Research involvement and engagement·2026
New-Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank.
International journal of cancer·2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice.
The lancet. Gastroenterology & hepatology·2026
A blood-based test for detection of advanced adenomas and colorectal cancer (DENEB): a multicentre diagnostic accuracy study.
The lancet. Gastroenterology & hepatology·2026
Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.
The lancet. Gastroenterology & hepatology·2026
Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial.
The lancet. Gastroenterology & hepatology·2026
Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.
The journal of vascular access·2026
Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.
Indian journal of pharmacology·2026
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
Journal of immunotherapy (Hagerstown, Md. : 1997)·2026
Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.
Expert review of pharmacoeconomics & outcomes research·2026